To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via

Status Completed

Clinical Trial Summary

This is a National, Multicentre, Observational Registry to study adherence and long term outcomes of therapy in paediatric subjects using Easypod™ electromechanical device for growth hormone treatment from hospitals in France and to assess the level of adherence of subjects receiving SAIZEN® via Easypod™.

Clinical Trial Description

Subjects will be enrolled in this observational, multi-center study to assess adherence and treatment outcomes. Parents will provide their written agreement to upload their child's data in the study electronic CRF.

Easypod™ is an electromechanical device that delivers growth hormone and also records injections' date and time. Adherence data will be primarily derived from injections recorded in the Easypod™ device combined with physician data entry of outcome measures (i.e. height & weight). This will allow the establishment of adherence profiles and evaluate the link with subsequent clinical outcomes.

Since this is an observational study, there will be no study-specific clinical interventions and subjects will be treated according to the clinical and laboratory findings as routinely evaluated by the physician. Auxological and laboratory data will be reported prospectively throughout the duration of the study. At baseline, available data can be recorded retrospectively from the subjects' medical file and Easypod™ device Data will be collected retrospectively and prospectively. This will allow the establishment of adherence profiles and subsequent clinical outcomes. Collected data will be also analyzed in a multinational pooled analysis of comparable national studies.

Primary Objective:

• To assess the level of adherence of subjects receiving Saizen® via Easypod™

Secondary Objectives:

- To describe the impact of adherence on clinical outcomes for subject receiving Saizen® via Easypod™

- To identify adherence subject profiling

- To asses the Impact of adherence on insulin-like growth factor-1 (IGF1) ranges/levels ;

Study Design

Related Conditions & MeSH terms

Growth Disorders

Clinical Trial Details

NCT number	NCT01291394
Study type	Observational
Source	Merck KGaA
Contact
Status	Completed
Phase	N/A
Start date	January 31, 2011
Completion date	December 31, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01376921` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain	N/A
Completed	`NCT01400997` - Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic	N/A
Completed	`NCT05244785` - Health and Nutrition Survey on Shenzhen Children
Completed	`NCT00097539` - A Postmarketing Surveillance Program for Nutropin, Nutropin AQ, and Protropin	Phase 4
Not yet recruiting	`NCT04576845` - The Effect of Early Childhood Cow's Milk Allergy Elimination Diet on Eating Behaviors, Nutrition, and Growth Status
Not yet recruiting	`NCT05056285` - Pattern of Growth and Characteristics of Down Syndrome Pediatrics Patients
Completed	`NCT01263457` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
Terminated	`NCT00330668` - Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency	Phase 3
Completed	`NCT00378859` - The Effect of Milk and Meat on IGFs in Prepubertal Boys	N/A
Not yet recruiting	`NCT05577130` - Growth Pattern and Characteristics of Cardiac Pediatric Patients
Recruiting	`NCT05033119` - PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
Completed	`NCT01402999` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary	N/A
Completed	`NCT01267526` - A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment	N/A
Completed	`NCT00139451` - Nutrients and Hormones: Effects in Boys With Disordered Growth	Phase 2
Terminated	`NCT03274973` - Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
Completed	`NCT02015286` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East	N/A
Completed	`NCT01582334` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina	N/A
Completed	`NCT01439061` - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy	N/A
Completed	`NCT00125164` - Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency	Phase 3
Completed	`NCT00174408` - Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France — ECOS FRA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms